Retrograde Femoral Nail for Broken Bones
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method for repairing broken thigh bones (femur) using the RFN-Advanced Retrograde Femoral Nailing System. The goal is to determine if this implant improves bone healing, reduces pain, and results in fewer complications compared to current methods. It targets individuals requiring surgery for a broken femur who have been evaluated at UCSD. Participants will contribute data on the effectiveness of this new design over a three-year period. As an unphased trial, this study provides participants the chance to contribute to innovative research that could enhance future treatment options.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that the RFN-Advanced Retrograde Femoral Nailing System is safe for fracture fixation?
Research shows that the RFN-Advanced Retrograde Femoral Nailing System is under testing to help fix broken thigh bones. Studies suggest that this new nail design might improve bone healing and stability. However, there is an 8.2% chance of mechanical failure.
The system is designed to stay in place better, which is crucial for healing fractures in the lower part of the thigh bone. While the results are promising, participants should consider both the potential benefits and risks.12345Why are researchers excited about this trial?
The RFN-Advanced Retrograde Femoral Nailing System is unique because it offers a new approach to stabilizing broken femur bones by using a retrograde insertion technique. Unlike traditional methods, which often involve antegrade nailing through the hip, this system allows for insertion through the knee, potentially reducing surgical trauma and improving recovery times. Researchers are excited about this treatment because it could lead to fewer complications, faster rehabilitation, and better alignment of the bone, which are significant improvements over current standard care options.
What evidence suggests that the RFN-Advanced Retrograde Femoral Nailing System is effective for broken bones?
Research shows that the RFN-Advanced Retrograde Femoral Nailing System, which participants in this trial will receive, could effectively treat broken thigh bones. Studies suggest that this system may promote better bone healing than older methods, such as using plates on the side of the bone. One study compared the RFN-Advanced system to traditional methods and found promising results in bone healing and alignment. The system improves how the metal rod is secured in the bone, addressing difficulties seen with older designs. Early reports indicate it might reduce issues like incorrect bone healing, a common problem with current methods.13456
Are You a Good Fit for This Trial?
Adults 18+ with a distal femur or femoral shaft fracture needing surgery can join this trial. They must be treated at UCSD, understand and consent to the study. Excluded are pregnant women, those in other drug studies within the last month, prisoners, and patients with severe diseases not under control.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the RFN-advanced Retrograde Femoral Nailing System implant for fracture fixation
Follow-up
Participants are monitored for functional status, healing rates, complication rates, and pain levels
What Are the Treatments Tested in This Trial?
Interventions
- RFN-Advanced Retrograde Femoral Nailing System
RFN-Advanced Retrograde Femoral Nailing System is already approved in United States, European Union, Canada for the following indications:
- Distal femur fractures
- Femoral shaft fractures
- Distal femur fractures
- Diaphyseal femur fractures
- Distal femur fractures
- Femoral shaft fractures
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
DePuy Synthes
Industry Sponsor